151 related articles for article (PubMed ID: 1385479)
41. Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors.
Fearon DT
Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):43-6. PubMed ID: 1718643
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues.
Endoh M; Yamashina M; Ohi H; Funahashi K; Ikuno T; Yasugi T; Atkinson JP; Okada H
Clin Exp Immunol; 1993 Oct; 94(1):182-8. PubMed ID: 8403504
[TBL] [Abstract][Full Text] [Related]
43. C3d,g deposits in inflammatory skin diseases: use of psoriatic skin as a model of cutaneous inflammation.
Basset-Séguin N; Porneuf M; Dereure O; Mils V; Tesnières A; Yancey KB; Guilhou JJ
J Invest Dermatol; 1993 Dec; 101(6):827-31. PubMed ID: 8245511
[TBL] [Abstract][Full Text] [Related]
44. Expression and characterization of membrane co-factor protein (MCP) in human skin.
Sayama K; Shiraishi S; Shirakata Y; Kobayashi Y; Seya T; Miki Y
J Invest Dermatol; 1991 Oct; 97(4):722-4. PubMed ID: 1940444
[TBL] [Abstract][Full Text] [Related]
45. Characterization of decay-accelerating factor (DAF) in human skin.
Sayama K; Shiraishi S; Shirakata Y; Kobayashi Y; Miki Y
J Invest Dermatol; 1991 Jan; 96(1):61-4. PubMed ID: 1702821
[TBL] [Abstract][Full Text] [Related]
46. The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function.
Holers VM; Kinoshita T; Molina H
Immunol Today; 1992 Jun; 13(6):231-6. PubMed ID: 1378280
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins.
Li Y; Jacques S; Gaikwad H; Wang G; Banda NK; Holers VM; Scheinman RI; Tomlinson S; Moghimi SM; Simberg D
Nat Nanotechnol; 2024 Feb; 19(2):246-254. PubMed ID: 37798566
[TBL] [Abstract][Full Text] [Related]
48. Expression of complement regulatory proteins on fetal blood cells in utero.
Jarvis JN; Moore HT; Fine N; Berry SM
Biol Neonate; 1996; 69(4):225-9. PubMed ID: 8724649
[TBL] [Abstract][Full Text] [Related]
49. C3d,g in normal human epidermal basement membrane.
Basset-Seguin N; Yancey KB
Acta Derm Venereol; 1990; 70(3):273. PubMed ID: 1972852
[No Abstract] [Full Text] [Related]
50. Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.
Carroll MC; Alicot EM; Katzman PJ; Klickstein LB; Smith JA; Fearon DT
J Exp Med; 1988 Apr; 167(4):1271-80. PubMed ID: 2451706
[TBL] [Abstract][Full Text] [Related]
51. A-431 cells and human keratinocytes synthesize and secrete the third component of complement.
Basset-Séguin N; Caughman SW; Yancey KB
J Invest Dermatol; 1990 Dec; 95(6):621-5. PubMed ID: 2250103
[TBL] [Abstract][Full Text] [Related]
52. In vitro complement binding on cytoplasmic structures in normal human skin: immunoelectronmicroscopic studies.
Schuler G; Hintner H; Wolff K; Fritsch P; Stingl G
J Cell Biol; 1982 Nov; 95(2 Pt 1):543-51. PubMed ID: 6754748
[TBL] [Abstract][Full Text] [Related]
53. Human keratinocytes and A-431 cells synthesize and secrete factor B, the major zymogen protease of the alternative complement pathway.
Yancey KB; Overholser O; Domloge-Hultsch N; Li LJ; Caughman SW; Bisalbutra P
J Invest Dermatol; 1992 Mar; 98(3):379-83. PubMed ID: 1545147
[TBL] [Abstract][Full Text] [Related]
54. Pillars Article: Identification of an Additional Class of C3-Binding Membrane Proteins of Human Peripheral Blood Leukocytes and Cell Lines.
Cole JL; Housley GA; Dykman TR; Macdermott RP; Atkinson JP
J Immunol; 2019 Jul; 203(1):6-10. PubMed ID: 31209142
[No Abstract] [Full Text] [Related]
55. Expression of the myelomonocytic antigens L1 and CD36 in human epidermis.
Barker JN; Allen MH; Griffiths CE; Nickoloff BJ; MacDonald DM
Br J Dermatol; 1990 Oct; 123(4):548-9. PubMed ID: 1710139
[No Abstract] [Full Text] [Related]
56. A new cell type in normal human epidermis?
De Panfilis G; Lonati A; Pasolini G; Manara GC; Torresani C; Ferrari C; Rowden G
J Invest Dermatol; 1992 Jan; 98(1):121-2. PubMed ID: 1370229
[No Abstract] [Full Text] [Related]
57. Pitfalls in the measurement of soluble forms of cell surface receptors.
Ling NR
Clin Exp Immunol; 1993 Aug; 93(2):139-41. PubMed ID: 8348738
[No Abstract] [Full Text] [Related]
58. Specific Evolution and Gene Family Expansion of Complement 3 and Regulatory Factor H in Fish.
Najafpour B; Cardoso JCR; Canário AVM; Power DM
Front Immunol; 2020; 11():568631. PubMed ID: 33381109
[TBL] [Abstract][Full Text] [Related]
59. Complement System in Cutaneous Squamous Cell Carcinoma.
Riihilä P; Nissinen L; Knuutila J; Rahmati Nezhad P; Viiklepp K; Kähäri VM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31331124
[TBL] [Abstract][Full Text] [Related]
60. Persistent Intracellular
Abu-Humaidan AH; Elvén M; Sonesson A; Garred P; Sørensen OE
Front Immunol; 2018; 9():396. PubMed ID: 29545804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
